BlackRock Inc (BLK)vsBlackRock Technology and Private Equity Term Trust (BTX)
BLK
BlackRock Inc
$1,061.79
-0.46%
FINANCIAL SERVICES · Cap: $175.42B
BTX
BlackRock Technology and Private Equity Term Trust
$9.05
+1.00%
FINANCIAL SERVICES · Cap: $1.04B
Smart Verdict
WallStSmart Research — data-driven comparison
BLK leads profitability with a 24.1% profit margin vs 0.0%. BTX trades at a lower P/E of 2.3x. BLK earns a higher WallStSmart Score of 78/100 (B+).
BLK
Strong Buy78
out of 100
Grade: B+
BTX
Avoid34
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 35.1%
Revenue surging 30.6% year-over-year
Large-cap with strong market position
Keeps 24 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Growing faster than its price suggests
Attractively priced relative to earnings
Areas to Watch
Moderate valuation
Weak financial health signals
Distress zone — elevated risk
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : BLK
The strongest argument for BLK centers on Operating Margin, Revenue Growth, Market Cap. Profitability is solid with margins at 24.1% and operating margin at 35.1%. Revenue growth of 30.6% demonstrates continued momentum.
Bull Case : BTX
The strongest argument for BTX centers on P/E Ratio.
Bear Case : BLK
The primary concerns for BLK are P/E Ratio, Piotroski F-Score, Altman Z-Score.
Bear Case : BTX
The primary concerns for BTX are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
BLK profiles as a growth stock while BTX is a value play — different risk/reward profiles.
BLK is growing revenue faster at 30.6% — sustainability is the question.
BTX generates stronger free cash flow (878M), providing more financial flexibility.
Monitor ASSET MANAGEMENT industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BLK scores higher overall (78/100 vs 34/100), backed by strong 24.1% margins and 30.6% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BlackRock Inc
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
BlackRock, Inc. is an American multinational investment management corporation based in New York City.
BlackRock Technology and Private Equity Term Trust
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. The company is headquartered in Brooklyn, New York.
Visit Website →Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?